Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-06-12 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DRAGUIGNAN (83300), Var
PHARMACIE DES HELLENES : revenue, balance sheet and financial ratios
PHARMACIE DES HELLENES is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DRAGUIGNAN (83300),
this company of category PME
shows in 2022 a revenue of 4.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES HELLENES (SIREN 498479849)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2016
Revenue
N/C
N/C
4 531 993 €
4 507 197 €
4 605 515 €
4 676 657 €
4 384 416 €
4 401 082 €
1 117 295 €
4 407 625 €
Net income
227 413 €
281 307 €
378 880 €
342 013 €
367 040 €
321 906 €
370 018 €
391 334 €
89 178 €
290 104 €
EBITDA
N/C
N/C
500 474 €
429 289 €
481 340 €
436 585 €
393 260 €
396 908 €
111 450 €
442 278 €
Net margin
N/C
N/C
8.4%
7.6%
8.0%
6.9%
8.4%
8.9%
8.0%
6.6%
Revenue and income statement
In 2024, PHARMACIE DES HELLENES generates positive net income of 227 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 290 k€ -> 227 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
227 413 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
37.501%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.306%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES HELLENES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
29.66
26.668
36.586
35.619
36.28
37.569
37.457
49.793
40.542
37.501
Financial autonomy
65.791
66.807
61.167
63.338
61.186
63.353
63.969
57.841
61.288
64.306
Repayment capacity
2.471
-10.125
2.988
3.297
2.852
2.75
3.114
3.58
None
None
Cash flow / Revenue
6.424%
-5.77%
6.422%
5.768%
6.291%
7.356%
6.891%
8.351%
None%
None%
Sector positioning
Debt ratio
37.52024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMACIE DES HELLENES (37.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.31%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DES HELLENES (64.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.58 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DES HELLENES (3.58) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 315.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
315.318
Liquidity indicators evolution PHARMACIE DES HELLENES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
302.903
216.849
215.976
244.389
217.066
299.294
331.593
294.963
272.502
315.318
Interest coverage
5.726
10.274
5.005
3.99
6.026
1.504
0.845
1.545
None
None
Sector positioning
Liquidity ratio
315.322024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE DES HELLENES (315.32) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.54x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE DES HELLENES (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES HELLENES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
816 116 €
817 044 €
766 492 €
784 460 €
1 073 293 €
937 222 €
1 411 429 €
1 559 595 €
0 €
0 €
Inventory turnover (days)
35
146
36
37
36
33
35
45
0
0
Customer payment term (days)
6
22
8
6
5
6
16
4
0
0
Supplier payment term (days)
33
139
40
26
55
44
41
56
0
0
Positioning of PHARMACIE DES HELLENES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES HELLENES is estimated at
3 174 853 €
(range 2 210 917€ - 4 749 762€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2210k€3174k€4749k€
3 174 853 €Range: 2 210 917€ - 4 749 762€
NAF 5 année 2024
Valuation method used
Net Income Multiple
227 413 €
×
14.0x
=3 174 854 €
Range: 2 210 918€ - 4 749 763€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES HELLENES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES HELLENES
What is the revenue of PHARMACIE DES HELLENES ?
The revenue of PHARMACIE DES HELLENES in 2022 is 4.5 M€.
Is PHARMACIE DES HELLENES profitable?
Yes, PHARMACIE DES HELLENES generated a net profit of 227 k€ in 2024.
Where is the headquarters of PHARMACIE DES HELLENES ?
The headquarters of PHARMACIE DES HELLENES is located in DRAGUIGNAN (83300), in the department Var.
Where to find the tax return of PHARMACIE DES HELLENES ?
The tax return of PHARMACIE DES HELLENES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES HELLENES operate?
PHARMACIE DES HELLENES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart